Endothelium and the brain in CNS lupus
- 1 December 2003
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 12 (12), 919-928
- https://doi.org/10.1191/0961203303lu503oa
Abstract
Central nervous system (CNS) involvement in systemic lupus erythematosus (SLE) is common and results in different clinical manifestations. Several pathogenic mechanisms have been suggested to play a rolein determiningsuch a varietyof clinicalsymptoms.The thrombophilicstateassociatedto the presence of antiphospholipidantibodies has been suggested to be responsible for a noninflammatory vasculopathywhichcauses clear ischaemiceventsas well as alterationsof the cerebralmicrocirculation that are likely associated to seizures, cognitive dysfunction or psychosis. Although less frequent, a true vasculitic process affecting cerebral circulation has also been reported. In both cases, brain endothelium does represent the target of the pathogenic mechanisms. Brain endothelial cells display peculiar functional and phenotypical characteristics in comparison with endothelial cells from other anatomical districts, raising the possibility that this might be the reason for its susceptibility in lupus disease. We review and present data suggesting that a higher and firmer expression of beta 2 glycoprotein I on endothelialcell membranes can be responsiblefor a selective damage/activation by circulating anti-beta 2 glycoprotein I, and that antiendothelial cell antibodies crossreact with brain endothelium and in some cases, specifically bind brain endothelial cells only in lupus patients with central nervous involvement.This publication has 45 references indexed in Scilit:
- CD154–CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosusArthritis & Rheumatism, 2002
- β 2 -Glycoprotein 1–Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial InfarctionStroke, 2001
- Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implicationsArthritis & Rheumatism, 2001
- Experimental Thrombosis and Antiphospholipid Antibodies: New InsightsJournal of Autoimmunity, 2000
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Vascular-Bed–Specific Hemostasis and Hypercoagulable StatesThe New England Journal of Medicine, 1999
- Serum Anti-β2-glycoprotein I Antibodies from Patients with Antiphospholipid Antibody Syndrome Bind Central Nervous System CellsJournal of Autoimmunity, 1998
- Exogenous tat protein activates central nervous system-derived endothelial cellsJournal of Neuroimmunology, 1994
- Increased immunoglobulin binding to cerebral endothelium in patients with antiphospholipid antibodies.Stroke, 1993
- Sneddon's syndrome: diagnosis by skin biopsy and MRI in 17 patients.Stroke, 1993